RxDoctor Payments Data

Naga Guntupalli, MD

Psychiatry · Kankakee, ILNPI 1518340231

Payments from drug & device makers

$7,242in general payments, 2019–2025

Across 376 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$1K
  • AbbVie$637
  • Lundbeck LLC$628
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$506
  • Johnson & Johnson$499
  • Alkermes, Inc.$498
  • plus $3K from 20 others

What the payments were for

  • Food & beverage$7,242100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,242 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois

Medicare billing

Part B allowed, 2024
$80,475
Medicare patients
282
Services billed
3,348

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl34$57,458
Abilify MaintenaAripiprazole13$35,418
RexultiBrexpiprazole23$29,621
Risperdal ConstaRisperidone Microspheres26$17,177
Aripiprazole120$12,194
Divalproex Sodium159$7,571
BelsomraSuvorexant16$7,246
Lurasidone Hcl20$6,970
Duloxetine Hcl228$4,949
Hydroxyzine Hcl212$4,738
Trazodone Hcl195$4,324
Quetiapine Fumarate170$4,099
CymbaltaDuloxetine Hcl13$3,670
Oxcarbazepine83$3,401
Clozapine83$3,349

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$1,136$65,04036 claims
AbbVieVraylar$637$57,45834 claims
Johnson & JohnsonRisperdal Consta$499$17,17726 claims
MerckBelsomra$76$7,24616 claims
Almatica Pharma LLCSertraline Hcl$218$1,337153 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,344 psychiatry providers in Illinois.

Other psychiatry in Kankakee

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →